Serelaxin Inhibits Lipopolysaccharide-induced Inflammatory Response in Cardiac Fibroblasts by Activating Peroxisome Proliferator-activated Receptor-γ and Suppressing the Nuclear Factor-Kappa B Signaling Pathway.

Details

Language :

English

ISSN :

01602446

Volume :

82

Issue :

3

Database :

Complementary Index

Journal :

Journal of Cardiovascular Pharmacology

Publication Type :

Academic Journal

Accession number :

171942785

Full Text :

https://doi.org/10.1097/fjc.0000000000001447